PNOC019: Neoadjuvant Checkpoint Inhibition in Recurrent or Progressive HGG

PNOC019: Neoadjuvant Checkpoint Inhibition in Recurrent or Progressive HGG

Es posible que algunos contenidos no estén disponibles en español.

Study Details

Full Title

A Randomized, Double-Blinded, Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG)

Principal Investigator

Daniel
Landi

Protocol Number

PRO00109073

NCT ID

NCT04323046

Phase

Pilot

Enrollment Status

Open to Enrollment
ClinicalTrials.gov